Platelet P2Y12 receptor inhibition by thienopyridines: status and future

Author： Porto Italo Giubilato Simona De Maria Giovanni Luigi Biasucci Luigi Marzio Crea Filippo

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.9, 2009-09, pp. : 1317-1332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet P2Y 12 Receptor Inhibition: An Update on Clinical Drug Development

By Vivas David Angiolillo Dominick J.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 217-226

Adis International

Access to resources Recommend Favorite

Biology and Pharmacology of the Platelet P2Y12 Receptor

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1255-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of platelet function by administration of MRS2179, a P2Y 1 receptor antagonist

By Baurand A. Raboisson P. Freund M. Leon C. Cazenave J.-P. Bourguignon J.-J. Gachet C.

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J Suryadevara Siva Capranzano Piera Bass Theodore A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1805-1812

Bentham Science Publishers

Access to resources Recommend Favorite